MedTrace Logo

Spoken Discourse Biomarker of PD Cognitive Impairment

NCT05909163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2023-06-18

No results posted yet for this study

Summary

The purpose of this study is to identify unique profiles of speech and language changes that distinguish individuals with Parkinson's disease from adults without Parkinson's disease and individuals with Parkinson's disease with cognitive (e.g., memory, thinking skills) impairment from those without cognitive impairment.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-05
Primary Completion
2023-02-15
Completion
2023-02-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05909163 on ClinicalTrials.gov